Alvenia Scarborough - Chemours Sr Officer

CC Stock  MXN 385.07  0.00  0.00%   

Insider

Alvenia Scarborough is Sr Officer of The Chemours
Age 49
Phone302 773 1000
Webhttps://www.chemours.com

Alvenia Scarborough Latest Insider Activity

Tracking and analyzing the buying and selling activities of Alvenia Scarborough against Chemours stock is an integral part of due diligence when investing in Chemours. Alvenia Scarborough insider activity provides valuable insight into whether Chemours is net buyers or sellers over its current business cycle. Note, Chemours insiders must abide by specific rules, including filing SEC forms every time they buy or sell Chemours'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Chemours Management Efficiency

The company has return on total asset (ROA) of 0.0653 % which means that it generated a profit of $0.0653 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.5281 %, meaning that it generated $0.5281 on every $100 dollars invested by stockholders. Chemours' management efficiency ratios could be used to measure how well Chemours manages its routine affairs as well as how well it operates its assets and liabilities.
The Chemours has accumulated 3.59 B in total debt with debt to equity ratio (D/E) of 529.2, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Chemours has a current ratio of 1.77, which is within standard range for the sector. Debt can assist Chemours until it has trouble settling it off, either with new capital or with free cash flow. So, Chemours' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Chemours sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Chemours to invest in growth at high rates of return. When we think about Chemours' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

David BemPPG Industries
53
Shlomo FrymermanVitro SAB de
N/A
Alfonso TamezVitro SAB de
N/A
Javier SantosVitro SAB de
N/A
Brian WilliamsPPG Industries
N/A
Bhaskar RamachandranPPG Industries
N/A
Andreas RutishauserALPEK SAB de
N/A
Jos GarzaALPEK SAB de
N/A
Armando CantuALPEK SAB de
N/A
Peg CurryPPG Industries
N/A
David GarzaALPEK SAB de
N/A
Francisco EgloffALPEK SAB de
N/A
Jos PeaALPEK SAB de
N/A
Alejandro MjicaVitro SAB de
69
Malesia DunnPPG Industries
N/A
Adrin MeouchiVitro SAB de
N/A
Jose ContrerasVitro SAB de
N/A
Ral HinojosaVitro SAB de
74
Alejandro FernandezALPEK SAB de
N/A
Ricardo MaizVitro SAB de
N/A
Roberto SanchezALPEK SAB de
N/A
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware. Chemours operates under Specialty Chemicals classification in Mexico and is traded on Mexico Stock Exchange. It employs 7000 people. The Chemours (CC) is traded on Mexican Exchange in Mexico and employs 6,600 people.

Management Performance

Chemours Leadership Team

Elected by the shareholders, the Chemours' board of directors comprises two types of representatives: Chemours inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Chemours. The board's role is to monitor Chemours' management team and ensure that shareholders' interests are well served. Chemours' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Chemours' outside directors are responsible for providing unbiased perspectives on the board's policies.
Mark Newman, CFO, Senior Vice President
Edwin Sparks, President - Chemical Solutions
Jonathan Lock, Sr Officer
Kurt Bonner, Ma Relations
Kristine Wellman, Gen VP
Alisha Bellezza, Director of Investor Relations
Sameer Ralhan, CFO, Senior Vice President Treasurer
Susan Kelliher, Senior Vice President – Human Resources and Health Services
Camela Wisel, Chief VP
Alvenia Scarborough, Sr Officer

Chemours Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Chemours a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Chemours Stock Analysis

When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.